Canada Spends Logo

Explore our Budget 2026 analysis

Grant: Doctoral Award - Frederick Banting and Charles Best Canada Graduate Scholarships

McMaster University

$105,000.00

Methodological Considerations of registry-based cluster-randomized controlled trials in hemodialysis

FY 2016-17

Summary
Dialysis is a life-saving treatment for the 23,000 Canadians and two million individuals worldwide whose kidneys have failed. These patients have very high death rates and are 30 times more likely to die compared to the general population at the same age. There are very few high quality studies that come from randomized controlled trials that test interventions to improve health outcomes for dialysis patients. Randomized controlled trials (RCT) randomly allocate patients to an intervention or control group and are often considered the gold standard evidence. Areas in medicine with the highest number of RCTs have experienced the most improvements in health outcomes (for example, cardiology). One of the reasons traditional RCTs are often not conducted in the dialysis population is because patients cross between the control and intervention groups, thus biasing the results of the study. For example, many patients are treated within the same dialysis centre. If nurses or the patients observe that other patients on the intervention have better outcomes, they may apply this intervention to patients in the control group. This defeats the purpose of randomization, contaminates the control group, and biases the results of the study. In contrast to traditional RCTs, cluster RCTs randomize intact groups (so the entire centre is on the same treatment). For example, for the 82 dialysis centres in Ontario, we would randomly assign 41 centres to the intervention and 41 centres to the control group. By design, cluster RCTs protect against bias from cross-group contamination. But, before we can begin conducting research using cluster RCTs, there are some practical challenges that require further study in the dialysis population. During my doctoral training, I will focus on these considerations and suggest appropriate adjustments to overcome those challenges. These findings can then be applied to future dialysis trials so we can produce high quality research that is free of bias.
Program
Doctoral Award - Frederick Banting and Charles Best Canada Graduate Scholarships
Location
Ontario, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database

As published

Id
365451
Name
Al-Jaishi Ahmed
Region
Ontario
Country
Canada
Orgtype
Institution Paid; Research Institution
Instname2
Health Services and Policy Research
Theme2
Health systems / services
Prcname2
Doctoral Research Awards - B
Projecttitle
Methodological Considerations of registry-based cluster-randomized controlled trials in hemodialysis
Programtype2
Studentship Programs
Orgnameinp2
McMaster University
Cihramount2
$105,000
Cihrequipment2
$0
Programname2
Doctoral Award - Frederick Banting and Charles Best Canada Graduate Scholarships
Keyworddelim
Administrative Data; Cluster Randomized Controlled Trials; Dialysis
Abstract
Dialysis is a life-saving treatment for the 23,000 Canadians and two million individuals worldwide whose kidneys have failed. These patients have very high death rates and are 30 times more likely to die compared to the general population at the same age. There are very few high quality studies that come from randomized controlled trials that test interventions to improve health outcomes for dialysis patients. Randomized controlled trials (RCT) randomly allocate patients to an intervention or control group and are often considered the gold standard evidence. Areas in medicine with the highest number of RCTs have experienced the most improvements in health outcomes (for example, cardiology). One of the reasons traditional RCTs are often not conducted in the dialysis population is because patients cross between the control and intervention groups, thus biasing the results of the study. For example, many patients are treated within the same dialysis centre. If nurses or the patients observe that other patients on the intervention have better outcomes, they may apply this intervention to patients in the control group. This defeats the purpose of randomization, contaminates the control group, and biases the results of the study. In contrast to traditional RCTs, cluster RCTs randomize intact groups (so the entire centre is on the same treatment). For example, for the 82 dialysis centres in Ontario, we would randomly assign 41 centres to the intervention and 41 centres to the control group. By design, cluster RCTs protect against bias from cross-group contamination. But, before we can begin conducting research using cluster RCTs, there are some practical challenges that require further study in the dialysis population. During my doctoral training, I will focus on these considerations and suggest appropriate adjustments to overcome those challenges. These findings can then be applied to future dialysis trials so we can produce high quality research that is free of bias.
Competitiondate
201610
Approvedterm2
3 yrs 0 mth
Pinamesdelim
Al-Jaishi, Ahmed
Approvedterm
3 ans 0 mois
Cihrcontribution2
~ $105,000~ $0~
McMaster University - $105,000 Grant (2016-17) | Canada Spends